Top Companies in the Implantable Sensor Orthopedic Market
Market Forecast
The worldwide implantable sensor orthopedic market is experiencing significant expansion, with projections indicating a revenue increase reaching several hundred million dollars by the end of the forecast period, spanning 2025 to 2034. This growth is driven by emerging trends and strong demand across key sectors.
Implantable Sensor Orthopedic Market Trends
- In June 2025, Lompoc Valley Medical Center conducted its first smart knee replacement surgery. The surgeon used Zimmer Biomet’s Persona IQ, the world’s first and only smart knee implant. The implant can measure the range of motion, step count, walking speed, and other gait metrics.
- In February 2025, Penderia Technologies announced that it received the FDA’s Breakthrough Device Designation for its Sensorized Soft Tissue Anchor System. The sensor addresses a critical gap in orthopedic soft tissue repair. The novel device uses an anchor, compatible with current surgical techniques, that is embedded with proprietary wireless sensing technology.
Value Chain Analysis – Implantable Sensor Orthopedic Market
R&D
Researchers conduct research activities to develop innovative implantable sensors using advanced technologies for orthopedic applications.
Key Players: Stryker Corporation, Medtronic, and DePuy Synthes.
Clinical Trials & Regulatory Approvals
Smart implants undergo clinical trials to assess their potential against numerous orthopedic disorders. Regulatory agencies, such as the FDA, NMPA, and EMA, give approval for these sensors based on the clinical trial data.
Patient Support & Services
Patient support & services refer to providing personalized treatment and educating patients about the use of orthopedic implants.
Latest Announcement by Industry Leaders
Stephen Laffoon, CEO at Penderia, commented that the company believes the platform will improve the standard of care in soft-tissue repairs and is excited to receive the Breakthrough Device designation as validation of the company’s vision. The company looks forward to engaging with the FDA through the TAP program as an important milestone on the way to clinical impact.
Recent Developments in the Implantable Sensor Orthopedic Market
- In May 2024, researchers from Yonsei University and Korea University developed a new human implantable, wireless, health monitoring electronic suture system for various orthopedic applications. The sensor contains a medical needle and thread to close or suture a wound.
- In March 2024, researchers from Peking University launched a miniaturized implantable sensor for monitoring health without the need for transcutaneous wires, reducing infection risks and improving biocompatibility. The system can measure critical parameters, such as intracranial pressure, orthopedic forces, and glucose levels.
Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com
